Ripple Science Announces Initiatives During COVID-19

Published on: 

Applied Clinical Trials

Ripple Science has announced new initiatives to help clinical researchers continue their research during this uncertain time by giving research teams free access to Ripple for their first study. For those working on COVID-19 trials directly, the company is providing six-months of access free of charge.

For more information, click here.